Dicerna Closes $25M Series B

The company will use the funds to advance its pipeline programs, including an effort in oncology, and to further develop its drug-delivery technologies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.